The presence of somatic variants in TP53 was also reported in SCD patients who later developed acute leukemia following HSCT failure or gene therapy, with pre-existing mutations sometimes identified at baseline [40,42,106,108,109]. Here, TP53 is linked to Schnyder corneal dystrophy.